Search

everythinglearnresearchcommunity

for

Search:↓

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Lipid–polymer hybrid nanoparticles can improve genome editing delivery and outcomes.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

Better supportive care is needed to manage chemotherapy side effects.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Cancer survivors need better skin care to improve their quality of life.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Stingless bee propolis may help regenerate hair follicles and improve pigment function in chemotherapy-induced hair loss.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

A group has developed therapies that show promise for treating cancer and various other conditions.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Improving hair health and managing conditions can enhance scalp cooling effectiveness in preventing hair loss during chemotherapy.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.